Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them
US11028070B2 · kind B2 · utility
1Cited by
3References
13Claims
0Family size
Assignees
Inventors
- James Edward Paul Davidson
- James Brooke Murray
- I-Jen Chen
- Claire Walmsley
- Mark Dodsworth
- Johannes W. G. Meissner
- Paul Brough
- Imre Fejes
- János Tatai
- Miklós Nyerges
- András Kotschy
- Zoltán Szlávik
- Olivier Geneste
- Arnaud Le Tiran
- Thierry Le Diguarher
- Jean-Michel Henlin
- Jérôme-Benoît Starck
- Anne-Françoise Guillouzic
- Guillaume De Nanteuil
Key dates
| Filing date | May 4, 2020 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | May 4, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65616
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compound of formula (I): wherein Het, R3, R4, R5, R7, R8, R9, t, p, p′, q, and q′ are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring pro-apoptotic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.